| - GRCh37:
- Chr20:44638517
- GRCh38:
- Chr20:46009878
| MMP9 | R51C | Metaphyseal anadysplasia 2 | Likely pathogenic (Mar 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr20:44640317
- GRCh38:
- Chr20:46011678
| MMP9 | G310fs | Metaphyseal anadysplasia 2 | Likely pathogenic (Mar 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr20:44639208
- GRCh38:
- Chr20:46010569
| MMP9 | P153Q | Metaphyseal anadysplasia 2, not provided | Uncertain significance (Jun 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:44641113
- GRCh38:
- Chr20:46012474
| MMP9 | G408S | Metaphyseal anadysplasia 2 | Uncertain significance (May 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr20:44637645
- GRCh38:
- Chr20:46009006
| MMP9 | T27I | not provided, Metaphyseal anadysplasia 2 | Uncertain significance (Aug 5, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:44644972
- GRCh38:
- Chr20:46016333
| LOC100128028, MMP9, SLC12A5-AS1 | V697M | not provided, Metaphyseal anadysplasia 2 | Uncertain significance (Sep 1, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:44640376
- GRCh38:
- Chr20:46011737
| MMP9 | C329* | Metaphyseal anadysplasia 2 | Pathogenic (Jan 2, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr20:44643033
- GRCh38:
- Chr20:46014394
| LOC100128028, MMP9, SLC12A5-AS1 | V642A | Metaphyseal anadysplasia 2 | Uncertain significance (Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr20:44643014
- GRCh38:
- Chr20:46014375
| LOC100128028, MMP9, SLC12A5-AS1 | D636H | Metaphyseal anadysplasia 2 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr20:44638625
- GRCh38:
- Chr20:46009986
| MMP9 | D87N | Metaphyseal anadysplasia 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr20:44638572
- GRCh38:
- Chr20:46009933
| MMP9 | P69L | not provided, Metaphyseal anadysplasia 2 | Uncertain significance (Aug 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:44638500
- GRCh38:
- Chr20:46009861
| MMP9 | | not provided, Metaphyseal anadysplasia 2 | Conflicting interpretations of pathogenicity (Sep 5, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr20:44642095
- GRCh38:
- Chr20:46013456
| MMP9 | P511L | Metaphyseal anadysplasia 2 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr20:44641967
- GRCh38:
- Chr20:46013328
| MMP9 | | not provided, Metaphyseal anadysplasia 2 | Conflicting interpretations of pathogenicity (Oct 17, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr20:44641957
- GRCh38:
- Chr20:46013318
| MMP9 | P465L | Metaphyseal anadysplasia 2 | Uncertain significance (Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr20:44640368
- GRCh38:
- Chr20:46011729
| MMP9 | G327R | Metaphyseal anadysplasia 2 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr20:44640305
- GRCh38:
- Chr20:46011666
| MMP9 | G306C | Metaphyseal anadysplasia 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr20:44639952
- GRCh38:
- Chr20:46011313
| MMP9 | E274K | Metaphyseal anadysplasia 2, not provided | Uncertain significance (Sep 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:44639914
- GRCh38:
- Chr20:46011275
| MMP9 | N261S | Metaphyseal anadysplasia 2, not provided | Conflicting interpretations of pathogenicity (Sep 10, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr20:44644954
- GRCh38:
- Chr20:46016315
| LOC100128028, MMP9, SLC12A5-AS1 | V691M | Metaphyseal anadysplasia 2 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr20:44639546
- GRCh38:
- Chr20:46010907
| MMP9 | | Metaphyseal anadysplasia 2, not provided | Conflicting interpretations of pathogenicity (Sep 7, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr20:44639201
- GRCh38:
- Chr20:46010562
| MMP9 | V151M | Metaphyseal anadysplasia 2 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr20:44638710
- GRCh38:
- Chr20:46010071
| MMP9 | K115R | Metaphyseal anadysplasia 2, not provided | Uncertain significance (Jul 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:44640229
- GRCh38:
- Chr20:46011590
| MMP9 | | Metaphyseal anadysplasia 2, not provided | Benign (Oct 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:44639599
- GRCh38:
- Chr20:46010960
| MMP9 | L187F | Metaphyseal anadysplasia 2, not provided | Benign/Likely benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:44644905
- GRCh38:
- Chr20:46016266
| LOC100128028, MMP9, SLC12A5-AS1 | | not provided, Metaphyseal anadysplasia 2 | Benign (Oct 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:44637646
- GRCh38:
- Chr20:46009007
| MMP9 | | not provided, Metaphyseal anadysplasia 2 | Conflicting interpretations of pathogenicity (Jul 23, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr20:44637678
- GRCh38:
- Chr20:46009039
| MMP9 | N38S | not provided, Metaphyseal anadysplasia 2 | Benign (Jan 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:44637635
- GRCh38:
- Chr20:46008996
| MMP9 | R24C | not provided, Metaphyseal anadysplasia 2 | Benign/Likely benign (Oct 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:44639956-44639961
- GRCh38:
- Chr20:46011317-46011322
| MMP9 | | Metaphyseal anadysplasia 2 | Uncertain significance (Nov 28, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr20:44642776
- GRCh38:
- Chr20:46014137
| LOC100128028, MMP9, SLC12A5-AS1 | W588* | not provided, Metaphyseal anadysplasia 2 | Uncertain significance (Mar 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:44642364
- GRCh38:
- Chr20:46013725
| LOC100128028, MMP9, SLC12A5-AS1 | W560* | not provided, Metaphyseal anadysplasia 2 | Uncertain significance (Sep 6, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:44641171-44641172
- GRCh38:
- Chr20:46012532-46012533
| MMP9 | P429fs | not provided, Metaphyseal anadysplasia 2 | Conflicting interpretations of pathogenicity (Oct 19, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr20:44645196
- GRCh38:
- Chr20:46016557
| LOC100128028, MMP9, SLC12A5-AS1 | | Metaphyseal anadysplasia 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr20:44645153
- GRCh38:
- Chr20:46016514
| LOC100128028, MMP9, SLC12A5-AS1 | | Metaphyseal anadysplasia 2, not provided | Benign (Mar 31, 2019) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:44645010
- GRCh38:
- Chr20:46016371
| LOC100128028, MMP9, SLC12A5-AS1 | | Metaphyseal anadysplasia 2, not provided | Benign (Oct 31, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:44644965
- GRCh38:
- Chr20:46016326
| LOC100128028, MMP9, SLC12A5-AS1 | | Metaphyseal anadysplasia 2, not provided | Benign (Oct 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:44644925
- GRCh38:
- Chr20:46016286
| LOC100128028, MMP9, SLC12A5-AS1 | R681H | Metaphyseal anadysplasia 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr20:44643111
- GRCh38:
- Chr20:46014472
| LOC100128028, MMP9, SLC12A5-AS1 | R668Q | Metaphyseal anadysplasia 2, not specified, not provided
| Benign (Oct 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:44642903
- GRCh38:
- Chr20:46014264
| LOC100128028, MMP9, SLC12A5-AS1 | R631S | Metaphyseal anadysplasia 2, not provided | Conflicting interpretations of pathogenicity (Sep 9, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr20:44642356
- GRCh38:
- Chr20:46013717
| MMP9, SLC12A5-AS1, LOC100128028 | | Metaphyseal anadysplasia 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr20:44641883
- GRCh38:
- Chr20:46013244
| MMP9 | | Metaphyseal anadysplasia 2, not provided | Benign (Oct 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:44640966
- GRCh38:
- Chr20:46012327
| MMP9 | | Metaphyseal anadysplasia 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr20:44640959
- GRCh38:
- Chr20:46012320
| MMP9 | | Metaphyseal anadysplasia 2, not provided | Benign (Nov 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:44640391
- GRCh38:
- Chr20:46011752
| MMP9 | | Metaphyseal anadysplasia 2, not provided | Benign (Oct 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:44640295
- GRCh38:
- Chr20:46011656
| MMP9 | C302* | Metaphyseal anadysplasia 2, not provided | Conflicting interpretations of pathogenicity (Jun 4, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr20:44640267
- GRCh38:
- Chr20:46011628
| MMP9 | I293N | Metaphyseal anadysplasia 2, not provided | Uncertain significance (Aug 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:44640225
- GRCh38:
- Chr20:46011586
| MMP9 | Q279R | not provided, Metaphyseal anadysplasia 2 | Benign (Nov 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:44639848
- GRCh38:
- Chr20:46011209
| MMP9 | R239H | not provided, Metaphyseal anadysplasia 2 | Benign/Likely benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:44639692
- GRCh38:
- Chr20:46011053
| MMP9 | | not specified, not provided, Metaphyseal anadysplasia 2
| Benign (Oct 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:44639214
- GRCh38:
- Chr20:46010575
| MMP9 | T155I | not provided, Metaphyseal anadysplasia 2 | Uncertain significance (Sep 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:44637624
- GRCh38:
- Chr20:46008985
| MMP9 | A20V | Metaphyseal anadysplasia 2, not provided | Benign/Likely benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:44637623
- GRCh38:
- Chr20:46008984
| MMP9 | A20T | Metaphyseal anadysplasia 2 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr20:44637610
- GRCh38:
- Chr20:46008971
| MMP9 | | Metaphyseal anadysplasia 2, not provided | Benign/Likely benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:44642833
- GRCh38:
- Chr20:46014194
| MMP9, SLC12A5-AS1, LOC100128028 | | not specified, not provided, Metaphyseal anadysplasia 2
| Benign (Nov 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:44639905
- GRCh38:
- Chr20:46011266
| MMP9 | T258I | not provided, Metaphyseal anadysplasia 2 | Conflicting interpretations of pathogenicity (Oct 26, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr20:44641977
- GRCh38:
- Chr20:46013338
| MMP9 | P472S | not provided, Metaphyseal anadysplasia 2 | Uncertain significance (Oct 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:44642406
- GRCh38:
- Chr20:46013767
| LOC100128028, MMP9, SLC12A5-AS1 | R574P | not specified, not provided, Metaphyseal anadysplasia 2
| Benign (Nov 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:44640275
- GRCh38:
- Chr20:46011636
| MMP9 | G296S | not provided, Metaphyseal anadysplasia 2 | Conflicting interpretations of pathogenicity (Oct 24, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr20:44637567
- GRCh38:
- Chr20:46008928
| MMP9 | M1K | not provided, Metaphyseal anadysplasia 2 | Uncertain significance (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |